<PAGE>
UNITED STATES
SECURITES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------------------------------------------
FORM 8-K
------------------------
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (Date of earliest event reported): January 8, 2001
COMMISSION FILE NUMBER 333-91845
CHARLES RIVER LABORATORIES, INC.
(Exact Name of Registrant as specified in its Charter)
DELAWARE 06-1397316
(State of Incorporation) (I.R.S. Employer Identification No.)
251 BALLARDVALE STREET, WILMINGTON, MASSACHUSETTS 01887
(Address of Principal Executive Offices) (Zip Code)
978-658-6000
(Registrant's Telephone Number, Including Area Code)
<PAGE>
ITEM 9. REGULATION FD DISCLOSURE
On January 8, the Registrant issued a press release announcing the
completion of the acquisition of Pathology Associates International Corporation.
The purpose of this Form 8-K is to furnish the press release for informational
purposes only. A copy of the press release is furnished with this Form 8-K as
Exhibit 99.1
EXHIBIT 99.1
Press Release dated January 8, 2001
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, we have duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CHARLES RIVER LABORATORIES, INC.
Dated: January 9, 2001
By: /s/ Dennis R. Shaughnessy
----------------------------------------
Dennis R. Shaughnessy, Sr. Vice President,
Business Development, General Counsel and
Secretary
